TIDMHCM
RNS Number : 9032W
Hutchmed (China) Limited
21 April 2023
Vesting of awards under the Long Term Incentive Plan
Hong Kong, Shanghai & Florham Park, NJ - Friday, April 21,
2023: HUTCHMED (China) Limited (" HUTCHMED ") (Nasdaq/AIM: HCM;
SEHK:13) announces that the non-performance based awards granted
under the Long Term Incentive Plan ("LTIP") on April 20, 2020 to
the following persons discharging managerial responsibilities were
vested on April 20, 2023:-
Number of American depositary
Award Holder shares ("ADS")
---------------------------------------------- -----------------------------
Mr Simon To (Executive Director) 2,397(1)
Dr Dan Eldar (Non-executive Director ("NED")) 2,397
Ms Edith Shih (NED) 2,397(2)
Mr Paul Carter (Independent Non-executive
Director ("INED")) 2,037(3)
Dr Karen Ferrante (INED) 2,397
Mr Graeme Jack (INED) 2,397
Professor Tony Mok (INED) 2,397
Notes:
(1) Similar to the arrangement for his Director's fees, these
ADSs were not received by Mr Simon To, but were received by or for
the account of his employer, Hutchison Whampoa (China) Limited.
(2) These ADSs were not received by Ms Edith Shih, but were
received by or for the account of her employer, Hutchison
International Limited.
(3) Mr Paul Carter elected, on acceptance of the grant of his
awards, to have 15% of his LTIP awards (amounting to US$7,500 with
respect to his awards which vested on April 20, 2023) held on his
behalf by the trustee administering the LTIP pending vesting in the
form of cash, to settle his tax liabilities in respect of his
awards.
The notifications set out below are provided in accordance with
the requirements of the UK Market Abuse Regulation.
(a) Dr Dan Eldar
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Dr Dan Eldar
------------------------------------------------------- -----------------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------------------------------
a) Position/status Non-Executive Director
------------------------------------------------------- -----------------------------------------------------
b) Initial notification/Amendment Initial notification
------------------------------------------------------- -----------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
--------------------------------------------------------------------------------------------------------------
a) Name HUTCHMED (China) Limited
------------------------------------------------------- -----------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
------------------------------------------------------- -----------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
--------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of ADS each representing five Ordinary Shares of
instrument US$0.10
Identification code
ADS ISIN: US44842L1035
------------------------------------------------------- -----------------------------------------------------
b) Nature of the transaction Vesting of awards granted on April 20, 2020 under
HUTCHMED's LTIP
------------------------------------------------------- -----------------------------------------------------
Price(s) Volume(s)
c) Price(s) and volume(s) Nil 2,397 ADS
----------
------------------------------------------------------- -----------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
------------------------------------------------------- -----------------------------------------------------
e) Date of the transaction 2023-04-20
------------------------------------------------------- -----------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------------------------- -----------------------------------------------------
(b) Mr Paul Carter
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Mr Paul Carter
------------------------------------------------------- -----------------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------------------------------
a) Position/status Independent Non-Executive Director
------------------------------------------------------- -----------------------------------------------------
b) Initial notification/Amendment Initial notification
------------------------------------------------------- -----------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
--------------------------------------------------------------------------------------------------------------
a) Name HUTCHMED (China) Limited
------------------------------------------------------- -----------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
------------------------------------------------------- -----------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
--------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of ADS each representing five Ordinary Shares of
instrument US$0.10
Identification code
ADS ISIN: US44842L1035
------------------------------------------------------- -----------------------------------------------------
b) Nature of the transaction Vesting of awards granted on April 20, 2020 under
HUTCHMED's LTIP
------------------------------------------------------- -----------------------------------------------------
Price(s) Volume(s)
c) Price(s) and volume(s) Nil 2,037 ADS
----------
------------------------------------------------------- -----------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
------------------------------------------------------- -----------------------------------------------------
e) Date of the transaction 2023-04-20
------------------------------------------------------- -----------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------------------------- -----------------------------------------------------
(c) Dr Karen Ferrante
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Dr Karen Ferrante
------------------------------------------------------- -----------------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------------------------------
a) Position/status Independent Non-Executive Director
------------------------------------------------------- -----------------------------------------------------
b) Initial notification/Amendment Initial notification
------------------------------------------------------- -----------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
--------------------------------------------------------------------------------------------------------------
a) Name HUTCHMED (China) Limited
------------------------------------------------------- -----------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
------------------------------------------------------- -----------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
--------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of ADS each representing five Ordinary Shares of
instrument US$0.10
Identification code
ADS ISIN: US44842L1035
------------------------------------------------------- -----------------------------------------------------
b) Nature of the transaction Vesting of awards granted on April 20, 2020 under
HUTCHMED's LTIP
------------------------------------------------------- -----------------------------------------------------
Price(s) Volume(s)
c) Price(s) and volume(s) Nil 2,397 ADS
----------
------------------------------------------------------- -----------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
------------------------------------------------------- -----------------------------------------------------
e) Date of the transaction 2023-04-20
------------------------------------------------------- -----------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------------------------- -----------------------------------------------------
(d) Mr Graeme Jack
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Mr Graeme Jack
------------------------------------------------------- -----------------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------------------------------
a) Position/status Independent Non-Executive Director
------------------------------------------------------- -----------------------------------------------------
b) Initial notification/Amendment Initial notification
------------------------------------------------------- -----------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
--------------------------------------------------------------------------------------------------------------
a) Name HUTCHMED (China) Limited
------------------------------------------------------- -----------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
------------------------------------------------------- -----------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
--------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of ADS each representing five Ordinary Shares of
instrument US$0.10
Identification code
ADS ISIN: US44842L1035
------------------------------------------------------- -----------------------------------------------------
b) Nature of the transaction Vesting of awards granted on April 20, 2020 under
HUTCHMED's LTIP
------------------------------------------------------- -----------------------------------------------------
Price(s) Volume(s)
c) Price(s) and volume(s) Nil 2,397 ADS
----------
------------------------------------------------------- -----------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
------------------------------------------------------- -----------------------------------------------------
e) Date of the transaction 2023-04-20
------------------------------------------------------- -----------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------------------------- -----------------------------------------------------
(e) Professor Tony Mok
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Professor Tony Mok
------------------------------------------------------- -----------------------------------------------------
2 Reason for the notification
--------------------------------------------------------------------------------------------------------------
a) Position/status Independent Non-Executive Director
------------------------------------------------------- -----------------------------------------------------
b) Initial notification/Amendment Initial notification
------------------------------------------------------- -----------------------------------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
--------------------------------------------------------------------------------------------------------------
a) Name HUTCHMED (China) Limited
------------------------------------------------------- -----------------------------------------------------
b) LEI 2138006X34YDQ6OBYE79
------------------------------------------------------- -----------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
--------------------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of ADS each representing five Ordinary Shares of
instrument US$0.10
Identification code
ADS ISIN: US44842L1035
------------------------------------------------------- -----------------------------------------------------
b) Nature of the transaction Vesting of awards granted on April 20, 2020 under
HUTCHMED's LTIP
------------------------------------------------------- -----------------------------------------------------
Price(s) Volume(s)
c) Price(s) and volume(s) Nil 2,397 ADS
----------
------------------------------------------------------- -----------------------------------------------------
d) Aggregated information N/A
- Aggregated volume
- Price
------------------------------------------------------- -----------------------------------------------------
e) Date of the transaction 2023-04-20
------------------------------------------------------- -----------------------------------------------------
f) Place of the transaction Outside a trading venue
------------------------------------------------------- -----------------------------------------------------
About HUTCHMED
HUTCHMED (Nasdaq/AIM:HCM; HKEX:13) is an innovative,
commercial-stage, biopharmaceutical company. It is committed to the
discovery and global development and commercialization of targeted
therapies and immunotherapies for the treatment of cancer and
immunological diseases. It has approximately 5,000 personnel across
all its companies, at the center of which is a team of about 1,800
in oncology/immunology. Since inception it has focused on bringing
cancer drug candidates from in-house discovery to patients around
the world, with its first three oncology drugs now approved and
marketed in China. For more information, please visit:
www.hutch--med.com or follow us on LinkedIn.
CONTACTS
Investor Enquiries
Mark Lee, Senior Vice President +852 2121 8200
Annie Cheng, Vice President +1 (973) 306- 4490
Media Enquiries
Americas - Brad Miles, +1 (917) 570 7340 (Mobile) / bmiles@s oleburystrat .com
Solebury Strategic Communications
Europe - Ben Atwell / Alex Shaw, +44 20 3727 1030 / +44 7771 913 902 (Mobile) / +44 7779 545 055
FTI Consulting (Mobile) / HUTCHMED@fticonsulting.com
Asia - Zhou Yi, Brunswick +852 97 83 6894 (Mobile) / HUTCHMED@brunswickgroup.com
Nominated Advisor
Atholl Tweedie / Freddy Crossley, Panmure Gordon +44 (20) 7886 2500
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHIMMPTMTJTMTJ
(END) Dow Jones Newswires
April 21, 2023 04:30 ET (08:30 GMT)
HUTCHMED China (AQSE:HCM.GB)
Historical Stock Chart
From Nov 2024 to Dec 2024
HUTCHMED China (AQSE:HCM.GB)
Historical Stock Chart
From Dec 2023 to Dec 2024
